Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Coordination and Locomotor Problems in Patients With Covid-19 Virus

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04734717
Recruitment Status : Enrolling by invitation
First Posted : February 2, 2021
Last Update Posted : February 2, 2021
Sponsor:
Information provided by (Responsible Party):
Tollár József, Somogy Megyei Kaposi Mór Teaching Hospital

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
Coordination and Locomotor Problems in Patients With Covid-19 Virus

Condition or disease Intervention/treatment Phase
Covid19 Motility Disorder Balance Diagnostic Test: Neurology test Not Applicable

Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 2 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Investigator)
Primary Purpose: Treatment
Official Title: Coordination and Locomotor Problems in Patients With Covid-19 Virus
Actual Study Start Date : January 12, 2021
Estimated Primary Completion Date : April 12, 2021
Estimated Study Completion Date : April 12, 2021

Resource links provided by the National Library of Medicine


Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: COVID19 Diagnostic Test: Neurology test
movement examination of patients with covid19 disease
Experimental: Controll Diagnostic Test: Neurology test
movement examination of patients with covid19 disease


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. EQ5D-5L [ Time Frame: 5 weeks-long ]
    Questionnaire

  2. Berg test [ Time Frame: 5 weeks-long ]
    Fatigue questionnaire

  3. SPPB test (gait, balance, leg stregth) [ Time Frame: 5 weeks-long ]
    Walking and balance testing

  4. 6MWT [ Time Frame: 5 weeks-long ]
    Walking test


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   20 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • COVID 19 diagnosis

Exclusion Criteria:

  • Severe heart problems
  • severe demeanor
  • alcoholism
  • drug problems
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04734717


Locations
Layout table for location information
Hungary
Dr. József Tollár
Kaposvár, Somogy, Hungary, 7400
Sponsors and Collaborators
Somogy Megyei Kaposi Mór Teaching Hospital
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Additional Information:

Layout table for additonal information
Responsible Party: Tollár József, Dr. József Tollár, Head of Neurorehabilitation ,7400 Kaposvár, Tallián Gy. u 20-32, Somogy Megyei Kaposi Mór Teaching Hospital
ClinicalTrials.gov Identifier: NCT04734717    
Other Study ID Numbers: IKEB2021/02
First Posted: February 2, 2021    Key Record Dates
Last Update Posted: February 2, 2021
Last Verified: February 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Tollár József, Somogy Megyei Kaposi Mór Teaching Hospital:
6MWT
Berg balance
Beam Walking
Additional relevant MeSH terms:
Layout table for MeSH terms
COVID-19
Respiratory Tract Infections
Infections
Pneumonia, Viral
Pneumonia
Virus Diseases
 Coronavirus Infections
Coronaviridae Infections
Nidovirales Infections
RNA Virus Infections
Lung Diseases
Respiratory Tract Diseases